PLx Pharma Secures $9,000,000 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=df053848-28c1-44da-bd08-3e0a8ae75a58 -
Date
7/9/2013 -
Company Name
PLx Pharma -
Mailing Address
8285 El Rio Houston, TX 77054 -
Company Description
PLx Pharma is a pharmaceutical company developing the next generation of non-steroidal anti-inflammatory agents (NSAIDs) that are safer on the gut. -
Website
http://www.plxpharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$9,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
